Literature DB >> 32437193

The importance of psychology for shaping legal cannabis regulation.

Jacob T Borodovsky1, Michael J Sofis2, Richard A Grucza1, Alan J Budney2.   

Abstract

Different patterns of cannabis use can be traced directly back to different interactions between 2 types of variables: pharmacological and environmental. As legal cannabis expands in the U.S. and around the world, state and national regulatory agencies are gaining control over these variables. Specifically, regulatory agencies are increasingly capable of altering (a) the pharmacological properties of cannabis products and (b) the way these products are distributed to the population. Consequently, cannabis regulatory agencies are in a unique position to use evidence from psychological science to alter cannabis consumption patterns in ways that mitigate potential harm to public health. However, most state-level legal cannabis regulatory systems in the U.S. are not yet evidence-based or public health-oriented. This applied review and commentary draws on evidence from the psychological science literature to help regulators better understand the types of behaviors they must address and guide empirically supported regulation of THC-laden cannabis, whether used putatively for medical or recreational reasons. This review is organized into 3 parts that correspond to the 3 primary agents within the cannabis regulation ecosystem: (a) the cannabis consumer, (b) the cannabis industry, and (c) the cannabis regulatory agency. Within this structure, the review addresses critical psychological variables that drive cannabis consumer and industry behaviors and discusses how regulatory agencies can use this information to protect public health. (PsycInfo Database Record (c) 2021 APA, all rights reserved).

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32437193      PMCID: PMC7679279          DOI: 10.1037/pha0000362

Source DB:  PubMed          Journal:  Exp Clin Psychopharmacol        ISSN: 1064-1297            Impact factor:   3.157


  185 in total

1.  Selective processing of cannabis cues in regular cannabis users.

Authors:  Matt Field; Brian Eastwood; Brendan P Bradley; Karin Mogg
Journal:  Drug Alcohol Depend       Date:  2006-05-15       Impact factor: 4.492

2.  Higher average potency across the United States is associated with progression to first cannabis use disorder symptom.

Authors:  Brooke J Arterberry; Hayley Treloar Padovano; Katherine T Foster; Robert A Zucker; Brian M Hicks
Journal:  Drug Alcohol Depend       Date:  2018-12-17       Impact factor: 4.492

3.  Anytime is the Right Time: A Content Analysis of Marijuana Ads in Freely Distributed Print Media in Western Washington State, USA.

Authors:  Beatriz H Carlini; Robin Harwick; Sharon Garrett
Journal:  Subst Use Misuse       Date:  2019-12-26       Impact factor: 2.164

4.  Reasons for Marijuana Use Among Young Adults and Long-Term Associations With Marijuana Use and Problems.

Authors:  Megan E Patrick; Bethany C Bray; Patricia A Berglund
Journal:  J Stud Alcohol Drugs       Date:  2016-11       Impact factor: 2.582

5.  Tax, price and cigarette smoking: evidence from the tobacco documents and implications for tobacco company marketing strategies.

Authors:  F J Chaloupka; K M Cummings; C P Morley; J K Horan
Journal:  Tob Control       Date:  2002-03       Impact factor: 7.552

Review 6.  A review of implicit and explicit substance self-concept as a predictor of alcohol and tobacco use and misuse.

Authors:  Kristen P Lindgren; Clayton Neighbors; Melissa L Gasser; Jason J Ramirez; Dario Cvencek
Journal:  Am J Drug Alcohol Abuse       Date:  2016-10-07       Impact factor: 3.829

7.  Cannabis use and cannabis use disorders among individuals with mental illness.

Authors:  Shaul Lev-Ran; Bernard Le Foll; Kwame McKenzie; Tony P George; Jürgen Rehm
Journal:  Compr Psychiatry       Date:  2013-01-31       Impact factor: 3.735

8.  Changes in cannabis potency and first-time admissions to drug treatment: a 16-year study in the Netherlands.

Authors:  Tom P Freeman; Peggy van der Pol; Wil Kuijpers; Jeroen Wisselink; Ravi K Das; Sander Rigter; Margriet van Laar; Paul Griffiths; Wendy Swift; Raymond Niesink; Michael T Lynskey
Journal:  Psychol Med       Date:  2018-01-31       Impact factor: 7.723

9.  Survey of Australians using cannabis for medical purposes.

Authors:  Wendy Swift; Peter Gates; Paul Dillon
Journal:  Harm Reduct J       Date:  2005-10-04

10.  Exploring cannabis concentrates on the legal market: User profiles, product strength, and health-related outcomes.

Authors:  L Cinnamon Bidwell; Sophie L YorkWilliams; Raeghan L Mueller; Angela D Bryan; Kent E Hutchison
Journal:  Addict Behav Rep       Date:  2018-08-17
View more
  2 in total

Review 1.  Cannabis use and cannabis use disorder.

Authors:  Jason P Connor; Daniel Stjepanović; Bernard Le Foll; Eva Hoch; Alan J Budney; Wayne D Hall
Journal:  Nat Rev Dis Primers       Date:  2021-02-25       Impact factor: 52.329

2.  Characterizing cannabis use reduction and change in functioning during treatment: Initial steps on the path to new clinical endpoints.

Authors:  Jacob T Borodovsky; Michael J Sofis; Brian J Sherman; Kevin M Gray; Alan J Budney
Journal:  Psychol Addict Behav       Date:  2022-01-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.